Latest Commissioning News

Calix Limited has secured a $44.9 million grant from ARENA to build a pioneering Green Iron Demonstration Plant using its ZESTY technology, aiming to produce 30,000 tonnes of low-emission iron annually and advance Australia’s green steel ambitions.

The South African Competition Commission has approved ASPI Isotopes’ offer to acquire Renergen Limited, marking a key regulatory milestone in the ongoing takeover process.

Adisyn Ltd has made significant strides in developing low-temperature graphene semiconductor interconnects, commissioning a new Atomic Layer Deposition system and securing a major managed IT services contract, while maintaining a strong cash position.

Lynas Rare Earths has achieved record quarterly production of key rare earth elements and reported a strong 38% increase in sales revenue, while advancing its Mt Weld expansion and signing strategic MOUs in Malaysia.

Deep Yellow Limited reports significant progress at its flagship Tumas uranium project in Namibia and successful pilot testing at Mulga Rock in Australia, supported by a robust cash position of A$217.4 million.

Ramelius Resources has officially withdrawn its conditional takeover bid for Spartan Resources following court approval of a competing scheme of arrangement, setting the stage for Spartan’s shares to be acquired under the scheme.

The Supreme Court of New South Wales has approved the acquisition scheme for AVJennings Limited, paving the way for a significant ownership change and imminent suspension of its shares on major exchanges.

IperionX has successfully commissioned its Virginia titanium manufacturing campus, secured a substantial U.S. Department of Defense contract, and raised $46 million to fast-track production expansion through 2030.

Paladin Energy outlines FY2026 operational ramp-up and financial guidance for its Langer Heinrich Mine, projecting increased uranium production and steady cost control ahead of full-scale operations in FY2027.

Iluka Resources has met its full-year zircon-in-concentrate production guidance by mid-2025 while progressing key projects like Balranald and Eneabba amid ongoing global trade uncertainties.

Spartan Resources Limited shares have been suspended from the ASX following court approval of a scheme of arrangement for its acquisition by Ramelius Resources Limited. This marks a significant step toward the consolidation of gold mining assets in Western Australia.

Telix Pharmaceuticals reported a robust 63% year-over-year revenue increase to $204 million in Q2 2025, launched its new prostate cancer imaging agent Gozellix in the U.S., and advanced key clinical trials despite an ongoing SEC inquiry.